You are here

Exforge

Novartis to pay $245 mln to end antitrust cases over Exforge drug generics

Reuters

Thu, 01/5/23 - 09:57 am

5 Blockbuster Drugs Going Off Patent in 2014

Motley Fool

Wed, 12/4/13 - 08:38 am

Sandostatin LAR

Top 10 Drug Patent Losses of 2014

Fierce Pharma

Mon, 10/28/13 - 10:26 am

Boehringer Ingelheim

Sandostatin LAR

Novartis says 3 drugs approved in Japan

Yahoo/AP

Wed, 01/20/10 - 06:33 pm

Novartis Looks at Combination Pills to Fix Hypertension Franchise

BNET Pharma

Wed, 11/25/09 - 07:40 am